Control of serum phosphate in patients with renal failure - new approaches

被引：15

作者：

Mucsi, I

Hercz, G

机构：

[1] Semmelweis Univ Med, Int Training & Res Ctr Nephrol, Dept Internal Med 1, Budapest, Hungary

[2] Univ Toronto, Humber River Reg Hosp, Toronto, ON, Canada

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 10期

关键词：

D O I：

10.1093/ndt/13.10.2457

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：2457 / 2460

页数：4

共 16 条

[1] METABOLIC BALANCE STUDIES AND DIETARY-PROTEIN REQUIREMENTS IN PATIENTS UNDERGOING CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].

BLUMENKRANTZ, MJ ;

KOPPLE, JD ;

MORAN, JK ;

COBURN, JW .

KIDNEY INTERNATIONAL, 1982, 21 (06) :849-861

[2] Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis [J].

Bro, S ;

Rasmussen, RA ;

Handberg, J ;

Olgaard, K ;

Feldt-Rasmussen, B .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) :257-262

[3]

Brooks DP, 1997, J PHARMACOL EXP THER, V281, P1440

[4]

Buoncristiani U, 1988, Kidney Int Suppl, V24, pS137

[5] SURVIVAL AS AN INDEX OF ADEQUACY OF DIALYSIS [J].

CHARRA, B ;

CALEMARD, E ;

RUFFET, M ;

CHAZOT, C ;

TERRAT, JC ;

VANEL, T ;

LAURENT, G .

KIDNEY INTERNATIONAL, 1992, 41 (05) :1286-1291

[6]

CHAUVEAU P, 1991, NEPHROL DIAL TRANS S, V2, P114

[7] Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure [J].

Chertow, GM ;

Burke, SK ;

Lazarus, JM ;

Stenzel, KH ;

Wombolt, D ;

Goldberg, D ;

Bonventre, JV ;

Slatopolsky, E .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (01) :66-71

[8]

DELMEZ JA, 1992, J AM SOC NEPHROL, V3, P96

[9]

*DEPT HLTH HUM SER, 1982, DEP HLTH HUM SERV PU, P1681

[10]

HAAS T, 1991, NEPHROL DIAL TRANSPL, V2, P108

← 1 2 →